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ABSTRACT  
 
 
We tested the hypothesis that family risk for psychosis (FR) and clinical risk for psychosis 
(CR) are associated with structural brain abnormalities, with increased deficits in those at 
both family risk and clinical risk for psychosis (FRCR). The study setting was the Oulu 
Brain and Mind Study, with subjects drawn from the Northern Finland 1986 Birth Cohort 
(n=9479) using register and questionnaire based screening, and interviews using the 
Structured Interview for Prodromal Symptoms. After this procedure, 172 subjects were 
included in the study, classified as controls (n=73) and three risk groups: FR excluding 
CR (FR, n=60), CR without FR (CR, n=26), and individuals at both FR and CR (FRCR, 
n=13). T1-weighted brain scans were acquired and processed in a voxel-based analysis 
using permutation-based statistics.  In the comparison between FRCR versus controls, 
we found lower grey matter volume (GMV) in a cluster (1689 voxels at -4.00, -72.00,-
18.00 mm) covering both cerebellar hemispheres and the vermis. This cluster was 
subsequently used as a mask to extract mean GMV in all four groups: FR had a volume 
intermediate between controls and FRCR. Within FRCR there was an association 
between cerebellar cluster brain volume and motor function. These findings are 
consistent with an evolving pattern of cerebellar deficits in psychosis risk with the most 
pronounced deficits in those at highest risk of psychosis. 
 
Keywords: Schizophrenia; family risk; clinical risk; prodrome; cerebellum; MRI 
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Introduction  
Schizophrenia is associated with brain structural abnormalities (Hulshoff Pol et al., 
2002; Meda et al., 2008; Tanskanen et al., 2010). At least some of the abnormalities 
are present at the time of initial diagnosis, leading to the hypothesis that these 
abnormalities develop in a prodromal or premorbid phase of illness (Steen et al., 
2006; Ellison-Wright et al., 2008). One approach to address this hypothesis has been 
to study people at risk of psychotic illness (Yung et al., 2004). This has the 
advantage of reducing potential confounds due to medication effects (Harrison, 
2003) or illness duration, and may have a clinical impact in improving early 
interventions available for this group of patients. 
 
Two main approaches have been taken to define transition risk to psychosis. The 
first has been studying those at genetic risk due to a family history of illness (Lawrie 
et al., 1999). The second has been studying those at risk due to the presence of 
clinical features (most notably sub-threshold psychotic symptoms) in help-seeking 
individuals recruited from specialist clinics (Yung et al., 2004). It remains unclear 
whether these two risk groups are associated with the same brain structural 
abnormalities as each other, or whether clinical and familial risk factors have their 
own unique brain structural signatures. It is also unknown whether or not these risk 
factors interact: if so, people with both risk factors would have the most pronounced 
brain deficits.  
 
We aimed to evaluate brain structure in psychosis risk profiles through a cross 
sectional comparison between young clinical risk, family risk and individuals with 
both family risk and clinical risk using voxel based morphometry. We conducted our 
study in the Oulu Brain and Mind Study (Veijola et al 2013), part of the Northern 
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Finland 1986 Birth Cohort (NFBC86), which sets our study in an epidemiologically 
principled framework. This provides an additional and complementary perspective on 
psychosis risk studies, which are more usually selected from clinic samples.  
 
We defined the population at clinical risk of psychosis in a two-stage approach: first 
we used a population based methodology that allowed us to screen our study 
subjects for non specific psychotic like symptoms and then a clinical interview that 
allowed us to detect those at higher risk of transition to psychosis. We used registry 
data to identify those at familial risk of psychosis and we combined information from 
registries and clinical interviews to define those individuals who were at both family 
and clinical risk for psychosis. We gathered structural MRI data on these individuals 
in order to test whether brain structure varies in different risk groups and whether 
there is a trend in brain structural abnormality such that those at both family and 
clinical risk have more severe abnormalities than those at family risk alone. 
 
Methods  
The Northern Finland 1986 Birth Cohort. 
The population from whom the participants were selected was composed of children 
with an expected date of birth between July 1st, 1985 and June 30th, 1986, in the 
two northernmost provinces of Finland (Oulu and Lapland). This population based 
birth cohort included 99 % of all births in the area at that time and consisted of 9479 
children, of whom 9432 were live-born (Jarvelin et al., 1997)  
(http://kelo.oulu.fi/NFBC). The ethical committee of Oulu University Hospital 
approved the study.  
 
 
Subject selection process: the Oulu Brain and Mind Study 
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Written informed consent was obtained from all participants. Details of subject 
selection are shown in Figure 1 and are described by Veijola and colleagues 
(Mukkala et al., 2011; Veijola et al., 2013).  To find a family risk group in the 1986 
cohort, subjects were also asked to participate if they had a parent with a diagnosis 
of any functional psychotic disorder or A-type personality disorder in the nationwide 
Finnish hospital discharge register between 1972-2005.  From those invited at family 
risk (272), 77 (33 males) agreed to participate and were finally scanned (28%).  
 
In order to define a group of individuals at clinical risk for psychosis, a stepped 
approach was used, in which we first defined an invitation group utilizing screening 
questionnaires for prodromal symptoms of psychosis in the general population. Then 
we invited those deemed at highest risk to a clinical assessment using the Structured 
Interview for Prodromal Syndromes (McGlashan et al., 2001) to identify individuals 
who met operation criteria for being at clinical risk for psychosis. The initial screening 
was performed in a procedure at age 15-16; cohort members were invited to 
complete a set of questionnaires, including the PROD-screen (Heinimaa et al., 
2003). We used the 21 item version calculating the final score based on 12 items, 
specifically probing for psychotic-like experiences (Yung et al., 2006). We recorded 
whether symptoms had been experienced (`no/yes') in the past 6 months. We also 
used the Youth Self-Report, YSR (Achenbach, 1991). From those invited, 74% 
(n=6795) participated in the screening (n=6298; 3043 boys). The cut off point was 
defined as subjects who had more than 2 symptoms in the Thought Disorder 
subscale (8 item) of the YSR and more than 2 specific symptoms (12 items) in the 
PROD-screen and who had had either no friends, had repeated a class in school or 
who had been treated in a psychiatric hospital due to non-psychotic disorder after the 
age of 12 until 2005. Furthermore, we invited also individuals who had been treated 
in hospital in 2003-2005 for substance abuse (ICD-10 diagnoses: F10-19);  mood, 
neurotic (F30-49) and personality disorders (F60-69), and  disorders of psychological 
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and developmental origin (F80-89). We term these individuals symptomatic risk. 
From those who were invited in the symptomatic risk group (n=137), 58 (24 males) 
were finally assessed with a detailed psychiatric assessment (42%), in order to 
determine who met clinical risk criteria according to operational criteria (see below). 
 
A control group was randomly selected representing about 1% of other cohort 
members having excluded any people who had first-degree relatives with a history of 
psychosis, symptomatic risk (based on invitation group), diagnosed psychosis, or 
ADHD (as the control group also served as controls for a study of ADHD, not 
presented here). From those 175 invited to join the control group, 80 (31 males) were 
finally scanned (46%).  
 
All the members of the groups were asked to participate in a clinical assessment 
during which examination with a psychiatric interview that used the SCID (Structured 
Clinical Interview with psychotic screen) (Spitzer et al., 1992) and the SIPS. This was 
performed to define those that either currently or previously met psychosis prodromal 
syndrome criteria:  we term these individuals to be at clinical risk for psychosis. We 
also invited cohort members with a previous diagnosis of ADHD or previous 
diagnosis of psychosis, and applied the same diagnostic interview in case they had 
been misclassified and in fact met clinical risk criteria. This procedure also allowed us 
to test subjects for clinical risk of psychosis in the control group and in the family risk 
group, so finally we could determine which individuals were at family risk of illness 
but not clinical risk, and which were at clinical risk but not family risk, and which 
individuals were at both family and clinical risk for psychosis.   
 
Final study groups 
After the diagnostic interviews (SIPS and SCID) were applied to all the people 
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participating, the groups were reclassified into three risk groups and controls 
(Table1). These risk groups were:  
 
Family Risk Group (FR) 
60 subjects with a parental history of psychosis and who did not meet clinical risk 
criteria. From those subjects included in this group, 18 had a parent with 
schizophrenia, 41 had parents with other psychosis, and 1 subject had a parent with 
A type personality disorder. 
 
Clinical Risk Group (CR) 
 This group was composed of 26 subjects who met prodromal syndrome criteria 
either currently or previously as defined by the SIPS and who did not meet family risk 
criteria. Fourteen patients from this group had been hospitalized receiving in patient 
treatment. 4 subjects had received outpatient treatment. Eight subjects had received 
no treatment at all. 1 member from this group had previously been misclassified as 
psychosis, and one came from a previous ADHD sample. 
 
Family plus Clinical Risk Group (FRCR) 
Composed of those subjects with a family history of psychosis according to the 
inclusion criteria of the invitation groups that subsequently and according to the SIPS 
were labeled as being at clinical risk of psychosis. This group was composed of 13 
subjects.  Two subjects had a parent with schizophrenia and 11 had a parent who 
had been diagnosed with other psychotic disorders. Five subjects from this group 
had been treated as outpatients and one had been hospitalized. Seven participants 
received no treatment. 
 
Control Group 
After applying the SIPS and SCID questionnaires and clinical interviews, 6 people 
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were excluded from the control group for clinical reasons (1 who met criteria for 
psychosis and 5 who met criteria for clinical risk of psychosis). One subject had to be 
excluded as well due to the very low quality of his scan. The group finally consisted 
of 73 people.  
 
The total number of people in these groups was 172. 
 
MRI data acquisition and preprocessing 
All subjects (n=172) were scanned using GE Signa EchoSpeed HDx 1.5 Tesla MRI 
scanner in Oulu University Hospital. T1-weighted images were acquired with 
inversion recovery (IR) prepared (”BRAVO”) 3D Fast Spoiled Gradient Echo 
(FSPGR) sequence using the following parameters: TR 12.4 ms, TE 5.2 ms, FA of 20 
degrees, FOV 24 cm x 24 cm, 256x256 acquisition matrix, 1 mm slice thickness, half 
k-space coverage in the phase encoding direction (GE ”fractional NEX” with 0.5 
factor). After scanning, three images from the total were excluded. One because of 
severe movement; one for very bad quality, due to interference in the magnetic field 
during the scanning and the last one due to a large ventricle enlargement that made 
it impossible to preprocess.  
 
Structural data was analyzed with FSL-VBM, a voxel-based morphometry style 
analysis (Ashburner and Friston 2000; Good et al., 2001) carried out with FSL tools. 
Structural images were brain-extracted using BET (Smith 2002.). Tissue-type 
segmentation was carried out using FAST4 (Zhang and Sejnowski, 2000). Resulting 
grey-matter partial volume images were then aligned to MNI152 standard space 
using the affine registration tool FLIRT followed by nonlinear registration using FNIRT 
which uses a b-spline representation of the registration warp field. The resulting 
images were averaged to create a study-specific template, to which the native grey 
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matter images were then non-linearly re-registered using FNIRT. The registered 
partial volume images were then modulated (to correct for local expansion or 
contraction) by dividing them by the Jacobian of the warp field. Finally the images 
were smoothed with a Gaussian kernel of full-width half-maximum of 1.175mm 
(sigma of 0.5). Note that because we use non-parametric statistics only minimal 
smoothing is required. 
 
 
Grooved Pegboard Test: 
As an assay of motor and cerebellar function, we collected data on the grooved 
pegboard test (Trites, 1989.) which is known to be abnormal in schizophrenia. It is a 
test of dexterity where subject must place 25 pegs to the board as quickly as 
possible with the dominant hand and non-dominant hand. The pegs are grooved, so 
placing the pegs resembles to putting a key to a lock. We used the outcome variable 
time to fill the pegboard with the dominant hand. 
 
 
Statistical analysis 
Modulated grey matter images were analyzed using CamBA permutation statistics 
(http://www.bmu.psychiatry.cam.ac.uk/software). Analyses of covariance (ANCOVA) 
using the General Linear Model framework were used to investigate focal GM 
volume differences between the controls and risk groups. We used gender, total 
intracranial volume (TIC) and handedness as covariates in all group comparisons. 
Results, corrected for multiple comparisons, were considered significant at the 
threshold of less than one error cluster per image, resulting in a p-threshold of less 
than 0.00029. We first performed analyses comparing single risk factor groups to 
controls using ANCOVA models: clinical risk (CR) versus controls, family risk (FR) 
	   10	  
versus controls, and the additive risk factor group of family plus clinical risk to 
controls (FRCR vs. controls). We hypothesized that both CR and FR groups would 
demonstrate differences from controls, and that the FRCR group would have the 
most pronounced abnormalities. In order to test this hypothesis we planned to use 
the results of the pairwise comparisons as a mask in which to perform tests to 
examine linear trends and order effects.  
 
Results.  
Voxelwise group comparisons of grey matter volume 
We found no significant differences when comparing the single risk groups (clinical 
risk or family risk) to controls. In the comparison between FRCR and controls we 
found that subjects in the additive risk group had lower grey matter density than 
controls bilaterally in the cerebellar hemispheres (anterior and posterior lobes) and 
vermis (Figure 2). This cluster had a size of 1689 voxels, peak voxel at -4.00, -72.00, 
-18.00 MNI space coordinates. In the anterior lobe the main regions with lower grey 
matter volume were the vermis and hemispheres involving mostly the right culmen 
and lingula in the vermis. In the posterior lobe the main region with grey matter deficit 
was the superior part of the posterior lobe especially around the declive and folium 
and the lateral hemispheric areas around the primary fissure. We used the cerebellar 
cluster as a mask to extract the mean grey matter volume for each individual for this 
area. We then compared the grey matter volumes we extracted across groups in 
order examine trend effects. 
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Cerebellar mask grey matter volumes comparison between 
groups 
After masking and extracting mean grey matter volumes for this cerebellum cluster in 
all four groups, we compared cerebellar grey matter volume between the FR groups 
and the CR group and controls, and tested whether the FR group has a cluster grey 
matter volume intermediate between controls and the FRCR group (Figure 3).  The 
FRCR group has less grey matter volume than FR alone in the cluster mask (T=5.4, 
df=84, p<0.001, one-tailed), and the FR group has less grey matter volume than the 
controls (T=1.9, df=131, p=0.03, one-tailed). This demonstrates that the FR group 
has an intermediate volume in this cluster between controls and the additive risk 
group, confirmed by a linear contrast across these three groups (p<0.001, 
F(1,143)=24.7). When we excluded one outlier (see Figure 3) with a low volume from 
the FR group from the analysis the linear trend across groups remained significant 
(p<0.001, F(1,142)=29.1) and the FR remained lower than the controls, but now with 
marginal (“trend-level”) statistical significance (T=1.6, df=130, p=0.0059, one-tailed). 
The CR group did not show lower grey matter volume in the cluster region than the 
controls (T=1.1, df=97, p=0.15 one-tailed).  
 
Correlation of the Grooved Pegboard Test scores with 
cerebellum grey matter volume. 
To examine the functional consequences of brain structural abnormality within the 
FRCR group, we regressed the degree of cerebellar structural deficits with the results 
for the dominant hand of the Grooved Pegboard Test, as this test has been shown to 
be sensitive to cerebellar lesions (Baser & Ruff 1987). Greater grey matter deficits 
predicted motor impairment after controlling for gender and total intracranial volume 
(p=0.023, Beta=0.006, T=2.7; Figure 4).  
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Discussion  
In an epidemiologically principled study, we demonstrated that individuals who have 
both family risk and clinical risk for psychosis have cerebellar structural deficits that 
predict performance on a test of motor function, the grooved pegboard test. A 
cerebellar deficit was also present in cohort members at family risk of psychosis but 
without clinical manifestations of psychosis.  
 
These findings signal the importance of cerebellar structural abnormalities in 
hereditary risk for psychosis. Cerebellar deficits have long been implicated in the 
origins and evolution of schizophrenia (Andreasen, 1999), and a recent meta-
analysis of voxel based morphometry studies of medication naïve psychosis patients 
identified the cerebellum as one of only two brain regions (the other was the insular 
cortex) with grey matter volume deficits in antipsychotic naïve patients (Fusar-Poli 
2011c). The model developed by Andreasen and colleagues (Andreasen et al., 1998) 
implicates deficits in the cerebellum producing a so-called "cognitive dysmetria," 
which entails difficulty in prioritizing, processing, coordinating, and responding to 
information, and our own previous findings from a related cohort, the Northern 
Finland 1966 Birth Cohort, provided evidence for abnormal cerebellar 
neurodevelopment in schizophrenia (Ridler et al., 2006) 
 
Of particular interest is our finding that there is a trend in structural cerebellar deficits 
such that family risk subjects have deficits compared to controls, but not as severe 
deficits as do those who have additive family risk and clinical risk. One potential 
explanation is that cerebellar deficits are a manifestation of genetic liability, such that 
those with the highest genetic loading for psychosis have both the most pronounced 
cerebellar deficits and other manifestations of disorder, such as clinical symptoms. 
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Alternatively, there may be an evolving pattern of deficits: as an individual at family 
risk for psychosis starts to develop clinical manifestations of illness, cerebellar brain 
abnormalities may concurrently progressively worsen. Longitudinal follow-up with 
repeat brain imaging of the individuals in this cohort (or similar cohorts) may help to 
decide between these interpretations.  
 
Our study utilises a unique methodology for risk group definition, which presents 
what we believe is an approach complementary to the majority of brain structural risk 
for psychosis studies, which tend to be either clinic based or family risk based, as 
opposed to examining both risk factors within the same population base. The 
framework we used to study subjects at high risk of psychosis was first to examine 
the role of single risk factors (clinical or family risk) on brain structure, then analyzing 
the additive effect of both risk factors (family plus clinical risk).  
 
We tried to separate the effects of prodromal symptoms from familial structural 
deficits. When we excluded clinical risk individuals from our family risk group, the 
comparison between the family risk group and controls showed no significant brain 
differences on voxelwise analysis. This may be surprising given that twin studies 
consistently show heritable structural deficits in schizophrenia and there have been 
several studies of patients at family risk of psychosis that show brain structural 
abnormalities in various brain regions, including the medial and lateral temporal lobe, 
the dorsolateral prefrontal cortex, medial prefrontal cortex, parietal cortex, cingulate 
cortex, precuneus,  (Bhojraj et al 2010; Bhojraj et al 2011; Kubicki et al., 2013; 
Smieskova et al., 2013). However, a closer reading of the literature reveals that the 
studies that have found brain structural differences in family risk individuals versus 
controls have usually employed region of interest analyses, which have increased 
power compared to whole brain analyses as they avoid the necessity to make 
corrections for multiple comparisons. Our family risk whole brain analysis family risk 
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null result is concordant with findings of other family risk group studies such as the 
Edinburgh High-Risk Study (Lawrie et al., 2001), where no differences were found on 
whole brain, voxel-wise analysis, and where differences were only found on region of 
interest based analyses. This matter has also been discussed in a review by Lawrie 
and colleagues  (2008), which showed that no previous study found differences in 
whole-brain, voxelwise analysis between a psychosis-offspring group and controls.  
 
It is also important to consider our negative results for the clinical risk group versus 
controls comparison. Several previous groups, have found differences on whole-
brain voxelwise analysis comparing those at clinical risk for psychosis versus controls 
(Pantelis et al., 2003; Borgwardt et al., 2007; Meisenzahl et al., 2008; Fusar-Poli et al 
2011). Although not all the studies have found deficits (Nakamura et al 2013), a 
meta-analysis of over 700 clinical risk subjects confirmed the presence of grey matter 
deficits in the right superior temporal gyrus, left precuneus, left medial frontal gyrus, 
right middle frontal gyrus, bilateral parahippocampal/hippocampal regions and 
bilateral anterior cingulate (Fusar-Poli et al 2011). It is therefore surprising that our 
CR group did not differ from controls in brain structure. One major difference 
between our CR group and previous studies’ CR group is that our group was not 
defined by help-seeking behaviour. It may be that brain structural deficits previously 
noted in persons at risk for psychosis attending prodromal clinics are partly 
associated with specific symptomatology but also partly associated with a general 
impairment of function, which is fairly intact in our CR group who had an average 
Global Assessment of Function (GAF) level of 69. Furthermore, the broad cognitive 
profile of our risk samples recruited from the general population is also fairly intact 
(Mukkala et al 2011), again suggesting that the participants in our risk samples are, 
compared to some previous risk studies, fairly healthy. Embedding our study within a 
population-based cohort allows us to make robust conclusions about psychosis risk 
in the general population. This has the advantage of avoiding the referral selection 
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effects that most clinical high-risk studies rely on, and it helps to ensure that our 
controls are truly representative of the population as opposed to being high-
functioning, supra-normal controls. However, it also may limit the power of our study 
to detect subtle effects.  
 
Whilst the only area in which we found differences between risk groups and controls 
was in the cerebellum, previous evidence indicates that there is more to the 
pathology of psychosis than cerebellar dysfunction; for example meta-analysis 
suggests widespread cortical and hippocampal deficits in schizophrenia (Ellison-
Wright et al 2008).  As our study was a straightforward voxel based morphometry 
study we did not examine gyrification patterns, or laterality effects such as torque 
(Crow et al 2013); our failure to document cortical deficits or laterality effects in our 
risk groups cannot be used as evidence that such abnormalities are not present, as 
absence of evidence is not evidence of absence.  
 
In summary, our results highlight the importance of cerebellum abnormalities in 
hereditary risk for psychosis. These abnormalities may be developmental in nature 
(as we detect them in those without symptoms) but may also be progressive, as they 
are more pronounced in those individuals who have both a presumed psychosis 
genotype (family history) and phenotypic expression (a history of subthreshold 
psychotic symptoms). 
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Figure Legends: 
 
Figure 1. Participant recruitment and constitution of groups. FHDR Finnish Hospital 
Discharge Registry. 2 subjects were recruited to the clinical risk group through other 
sources (see text for details). After the SIPS interview, individuals deemed to be 
psychotic patients were subsequently excluded from the study. Participants with poor 
scan quality were also excluded. 
 
Figure 2. Regions marked in blue indicate where people with both family and clinical 
risk for psychosis have lower grey matter volume than controls. 
 
Figure 3. Cerebellum cluster volume in cubic cm by psychosis risk group.  
 
Figure 4. Scatter plot of the regression analysis performed on the cerebellum cluster 
grey matter volume, against the dominant hand performance of the pegboard task in 
the family and clinical risk group (regression analysis: p=0.023, Beta=0.006, T=2.7). 
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Table	  1.	  Demographic	  Description	  of	  the	  Psychosis	  Risk	  Groups	  for	  the	  Structural	  MRI	  
	   	   General	  
population	  
controls	  	  
(n=	  73)	  
Family	  Risk	  	  
(n	  =	  60)	  
Clinical	  Risk	  
(n	  =	  26)	  
Family	  and	  
Clinical	  Risk	  
(n	  =	  13)	  
Total	  
(n	  =	  172)	  
Age	   	   21.96	  (0.68)	   22.09	  (0.7)	   22.08	  (0.69)	   21.79	  (0.7)	   21.98	  (0.69)	  
Sex	   	   43	  F:	  30	  M	   27	  F:	  33	  M	   17	  F:	  9	  M	   12	  F:	  1	  M	   99	  F:	  73	  M	  
Handedness	   	   69	  R:	  4	  L	   52	  R:	  8	  L	   26	  R:	  0	  L	   12	  R:	  1	  L	   159	  R:	  13	  L	  
IQ	   Mean	  (std	  dev)	   109.52	  (20.9)	   108.67	  (21.6)	   115.38	  (25.2)	   111.15	  (22.8)	   111.18	  (22.6)	  
Educational	  
Level	  
No	  information	   1	   0	   0	   0	   1	  <9	  School	  years	   0	   1	   0	   0	   1	  High	  School	  enrolment	   23	   29	   15	   2	   69	  High	  School	  Graduation	   49	   30	   11	   11	   101	  
GAF	  current	   Mean	  (std	  dev)	   80.47	  (SD	  16.15)	   83.63	  (SD	  7)	   68.58	  (SD	  15.3)	   72.38	  (SD	  12.38)	   76.24	  (10.9)	  
SOPS	  Score	  for	  
Positive	  
Symptoms	  
Mean	  (std	  dev)	   1.09	  (1.5)	   1.13	  (1.5)	   9.19	  (3.72)	   7.15	  (3.87)	   	  
Family	  
Members	  
Diagnosis	  of	  
the	  Family	  
Risk	  Group	  
(FHDR	  1972-­‐	  
2005)	  
Schizophrenia	  Spectrum	   0	   23	   0	   3	   26	  Schizoaffective	   0	   10	   0	   0	   10	  Bipolar	  Psychosis	   0	   5	   0	   5	   10	  Psychotic	  Depression	   0	   12	   0	   1	   13	  Delusional	  disorder	   0	   5	   0	   2	   7	  Other	  Psychoses	   0	   5	   0	   2	   7	  
Psychosis	  
diagnosis	  of	  
either	  father	  
or	  mother	  
Family	  Risk	  
Group	  
Mother,	  psychosis	  1972-­‐2005	   0	   41	   0	   6	   47	  Father,	  psychosis	  1972-­‐2005	   0	   19	   0	   7	   26	  No	  data	   0	   0	   0	   0	   0	  
I	  drink	  too	  
much	  alcohol	  
or	  get	  drunk	  
***	  
Not	  true	   72	   22	   49	   6	   149	  Somewhat	  or	  sometimes	  true	   1	   17	   11	   4	   33	  Very	  true	  or	  often	  true	   0	   1	   0	   3	   4	  
I	  use	  drugs,	  
for	  
nonmedical	  
purposes:	  ***	  
Not	  true	   72	   59	   22	   12	   165	  Somewhat	  or	  sometimes	  true	   1	   1	   3	   1	   6	  Very	  true	  or	  often	  true	   0	   0	   1	   0	   1	  
Alcohol	  use	  
disorder	  *	  
until	  2008	  
	   0	   1	   1	   0	   2	  
Cannabis	  use	  
disorder	  *	  
until	  2008	  
	   0	   0	   2	   0	   2	  
Other	  
substance	  use	  
disorder	  *	  	  
	   0	   0	   3	   0	   3	  
Drug	  use	  
detected	  by	  
urine	  sample	  
**	  
Amphetamine	  and	  other	  stimulants	   0	   0	   0	   0	   0	  Benzodiazepine	   0	   1	   0	   0	   1	  Buprenorphine	   0	   0	   0	   0	   0	  
	   18	  
Cannabis	   1	   0	   3	   0	   4	  Cocaine	   0	   0	   0	   0	   0	  Opioids	   1	   0	   0	   0	   1	  All	  drugs	   2	   1	   3	   0	   6	  
History	  of	  
Psychiatric	  
Treatment****	  
No	  treatment	   60	   8	   42	   7	   117	  Inpatient	   1	   14	   6	   1	   22	  Outpatient	   11	   4	   12	   5	   32	  *Finnish	  Hospital	  Discharge	  register	  	  (FHDR)	  until	  2008	  **Drug	  use	  was	  measured	  at	  the	  time	  of	  the	  scan	  with	  a	  urine	  sample	  ***Adult	  Self	  Report	  (ASR)	  items	  (Achenbach	  scale)	  ****	  History	  of	  psychiatric	  treatment	  was	  assessed	  with	  self-­‐report	  in	  the	  clinical	  examination	  and	  with	  register	  data	  on	  in-­‐patient	  admissions	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